Overview

Safety, Tolerability and Pharmacokinetic Study of MB12066 in Healthy Male Volunteers

Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the safety and tolerability of MB12066 after multiple dose and to investigate the pharmacokinetic characteristics of MB12066 after multiple dose.
Phase:
Phase 1
Details
Lead Sponsor:
KT&G Life Sciences Corp
Yungjin Pharm. Co., Ltd.
Treatments:
Beta-lapachone